These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28438056)

  • 1. Mass spectrometry analysis for amyloidosis typing - is the future bright for its clinical implementation?
    Hill MM; Mollee PN
    Expert Rev Proteomics; 2017 Jul; 14(7):565-566. PubMed ID: 28438056
    [No Abstract]   [Full Text] [Related]  

  • 2. How do we improve treatments for patients with amyloidosis using proteomics?
    Lavatelli F; Merlini G
    Expert Rev Proteomics; 2017 Jul; 14(7):561-563. PubMed ID: 28524784
    [No Abstract]   [Full Text] [Related]  

  • 3. Proteomics in Pathology.
    Longuespée R; Casadonte R; Schwamborn K; Reuss D; Kazdal D; Kriegsmann K; von Deimling A; Weichert W; Schirmacher P; Kriegsmann J; Kriegsmann M
    Proteomics; 2018 Jan; 18(2):. PubMed ID: 29236356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics in molecular diagnosis: typing of amyloidosis.
    Loo D; Mollee PN; Renaut P; Hill MM
    J Biomed Biotechnol; 2011; 2011():754109. PubMed ID: 22131817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proteomics, a new tool for an accurate typing of amyloidosis].
    Colombat M; Holifanjaniaina S; Onifarasoaniaina S; Valleix S; Maisonneuve H; Kahn JE;
    Rev Med Interne; 2015 May; 36(5):346-51. PubMed ID: 25544147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New advances in the subtyping of systemic amyloidosis].
    Sun WY; Li J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):259-62. PubMed ID: 24598691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of Amyloidosis by Model-Assisted Mass Spectrometry-Based Proteomics.
    Palstrøm NB; Rojek AM; Møller HEH; Hansen CT; Matthiesen R; Rasmussen LM; Abildgaard N; Beck HC
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical Laboratory Test Using Proteomics: The Usefulness of Proteomic Techniques for Amyloid Typing].
    Tasaki M; Obayashi K; Ando Y
    Rinsho Byori; 2015 Aug; 63(8):980-5. PubMed ID: 26638436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis.
    Sethi S; Vrana JA; Theis JD; Leung N; Sethi A; Nasr SH; Fervenza FC; Cornell LD; Fidler ME; Dogan A
    Kidney Int; 2012 Jul; 82(2):226-34. PubMed ID: 22495291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of systemic amyloid deposits by mass spectrometry.
    Murphy CL; Wang S; Williams T; Weiss DT; Solomon A
    Methods Enzymol; 2006; 412():48-62. PubMed ID: 17046651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac amyloidosis: pathology, nomenclature, and typing.
    Maleszewski JJ
    Cardiovasc Pathol; 2015; 24(6):343-50. PubMed ID: 26361138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress and pitfalls of using isobaric mass tags for proteome profiling.
    Dayon L; Affolter M
    Expert Rev Proteomics; 2020 Feb; 17(2):149-161. PubMed ID: 32067523
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical proteomics for diagnosis and typing of systemic amyloidoses.
    Brambilla F; Lavatelli F; Merlini G; Mauri P
    Proteomics Clin Appl; 2013 Jan; 7(1-2):136-43. PubMed ID: 23184874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue.
    Brambilla F; Lavatelli F; Di Silvestre D; Valentini V; Rossi R; Palladini G; Obici L; Verga L; Mauri P; Merlini G
    Blood; 2012 Feb; 119(8):1844-7. PubMed ID: 21917755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying proteomics to detect early signs of chronic kidney disease: where has the magic gone?
    Klein JB
    Expert Rev Proteomics; 2017 May; 14(5):387-390. PubMed ID: 28363249
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyphenated Mass Spectrometry Techniques in the Diagnosis of Amyloidosis.
    Spodzieja M; Rodziewicz-Motowidło S; Szymanska A
    Curr Med Chem; 2019; 26(1):104-120. PubMed ID: 28971756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International competition on mass spectrometry proteomic diagnosis.
    Mertens B
    Stat Appl Genet Mol Biol; 2008; 7(2):Article1. PubMed ID: 19852745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of Mass Spectrometry-Based Targeted Analysis for Amyloid Proteins.
    Park J; Lee GY; Choi JO; Jeon ES; Kim K; Kim JS; Lee SY
    Proteomics Clin Appl; 2018 May; 12(3):e1700106. PubMed ID: 29266842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic amyloidosis from A (AA) to T (ATTR): a review.
    Muchtar E; Dispenzieri A; Magen H; Grogan M; Mauermann M; McPhail ED; Kurtin PJ; Leung N; Buadi FK; Dingli D; Kumar SK; Gertz MA
    J Intern Med; 2021 Mar; 289(3):268-292. PubMed ID: 32929754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloidosis: Insights from Proteomics.
    Dogan A
    Annu Rev Pathol; 2017 Jan; 12():277-304. PubMed ID: 27959636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.